ResMed Inc $ 176.53 -26.43 (-13.02%)
Volume:
1,270,339
Avg Vol (1m):
652,414
Market Cap $:
25.66 Bil
Enterprise Value $:
26.81 Bil
P/E (TTM):
50.25
P/B:
11.38
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.23 | ||
| Equity-to-Asset | 0.5 | ||
| Debt-to-Equity | 0.67 | ||
| Debt-to-EBITDA | 1.78 | ||
| Interest Coverage | 17.32 | ||
| Piotroski F-Score | 6 | ||
| Altman Z-Score | 10.03 | ||
| Beneish M-Score | -2.46 | ||
| WACC vs ROIC | |||
Profitability Rank | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 26.2 | ||
| Net Margin % | 17.73 | ||
| ROE % | 23.9 | ||
| ROA % | 12.08 | ||
| ROC (Joel Greenblatt) % | 67.1 | ||
| 3-Year Revenue Growth Rate | 11.6 | ||
| 3-Year EBITDA Growth Rate | 8.8 | ||
| 3-Year EPS without NRI Growth Rate | 4 |
Valuation Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 51.1 | ||
| Forward PE Ratio | 38.98 | ||
| PE Ratio without NRI | 51.1 | ||
| Price-to-Owner-Earnings | 57.74 | ||
| PB Ratio | 11.57 | ||
| PS Ratio | 9.07 | ||
| Price-to-Free-Cash-Flow | 51.93 | ||
| Price-to-Operating-Cash-Flow | 42.7 | ||
| EV-to-EBIT | 41.25 | ||
| EV-to-EBITDA | 32.17 | ||
| EV-to-Revenue | 9.42 | ||
| PEG Ratio | 8.1 | ||
| Shiller PE Ratio | 72.35 | ||
| Current Ratio | 2.66 | ||
| Quick Ratio | 2.01 | ||
| Days Inventory | 110.5 | ||
| Days Sales Outstanding | 70.04 | ||
| Days Payable | 36.39 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 0.86 | ||
| Dividend Payout Ratio | 0.44 | ||
| 3-Year Dividend Growth Rate | 7.2 | ||
| Forward Dividend Yield % | 0.86 | ||
| 5-Year Yield-on-Cost % | 1.14 | ||
| 3-Year Average Share Buyback Ratio | -0.7 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 3.48 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 3.53 | ||
| Price-to-Median-PS-Value | 1.88 | ||
| Price-to-Peter-Lynch-Fair-Value | 5.1 | ||
| Earnings Yield (Greenblatt) % | 2.41 | ||
| Forward Rate of Return (Yacktman) % | 11.44 |